Gates Foundation – Visterra, Strategic Relationship Letter Agreement Post author:GHIAA Admin Post published:September 19, 2023 Post category: Continue ReadingGates Foundation – Visterra, Strategic Relationship Letter Agreement
U.S. Department of Defense – Inovio, COVID-19 Vaccine Delivery Device, Other Transaction Prototype Agreement Post author:GHIAA Admin Post published:September 4, 2023 Post category: Continue ReadingU.S. Department of Defense – Inovio, COVID-19 Vaccine Delivery Device, Other Transaction Prototype Agreement
NIH – UniQure, AAV5 Gene Therapies Exclusive and Non-Exclusive License Agreement Post author:GHIAA Admin Post published:September 4, 2023 Post category: Continue ReadingNIH – UniQure, AAV5 Gene Therapies Exclusive and Non-Exclusive License Agreement
PHS (NIH/CDC/FDA), Model Exclusive Patent License Agreement Post author:GHIAA Admin Post published:August 31, 2023 Post category: Continue ReadingPHS (NIH/CDC/FDA), Model Exclusive Patent License Agreement
PHS – Aridis, Rotavirus Vaccine Exclusive and Non-Exclusive License Agreement Post author:GHIAA Admin Post published:August 28, 2023 Post category: Continue ReadingPHS – Aridis, Rotavirus Vaccine Exclusive and Non-Exclusive License Agreement
PHS – Biosyn, HIV Prophylactic Exclusive License Agreement Post author:GHIAA Admin Post published:August 25, 2023 Post category: Continue ReadingPHS – Biosyn, HIV Prophylactic Exclusive License Agreement
NIH – Fluidigm, COVID-19 Diagnostic Development Agreement Post author:GHIAA Admin Post published:August 24, 2023 Post category: Continue ReadingNIH – Fluidigm, COVID-19 Diagnostic Development Agreement
NIH – Non-Profit, Model License Agreement Terms Post author:GHIAA Admin Post published:August 11, 2023 Post category: Continue ReadingNIH – Non-Profit, Model License Agreement Terms
DNDi Template Development Collaboration and License Agreement Post author:GHIAA Admin Post published:April 20, 2023 Post category: Continue ReadingDNDi Template Development Collaboration and License Agreement